These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 7469704

  • 1. [Role and therapeutic use of deferoxamine in iron overload due to thalassemia (author's transl)].
    Lévy G, Bachelot C, Joannard A, Bost M.
    Arch Fr Pediatr; 1980 May; 37(5):299-303. PubMed ID: 7469704
    [Abstract] [Full Text] [Related]

  • 2. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE, Hagiwara M, Thomas SK, Baladi JF, Phatak PD, Coates TD.
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [Abstract] [Full Text] [Related]

  • 3. [The echocardiography in thalassemia major (author's transl)].
    Musumeci S, Schiliro G, Romeo MA, Di Gregorio F, Russo G, Scibilia G.
    Pediatr Med Chir; 1981 Apr; 3(2-3):219-22. PubMed ID: 6211659
    [Abstract] [Full Text] [Related]

  • 4. Iron chelating therapy in thalassemia: current problems.
    Russo G.
    Haematologica; 1990 Apr; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract] [Full Text] [Related]

  • 5. [Thalassemia major: chelating therapy with deferoxamine].
    Abreu de Miani MS, Sanchis de Herrlein MS, Peñalver JA.
    Medicina (B Aires); 1985 Apr; 45(3):231-4. PubMed ID: 3841934
    [No Abstract] [Full Text] [Related]

  • 6. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
    Krüger N, Kijewski H, König R, Tillmann W, Schröter W.
    Dtsch Med Wochenschr; 1984 Nov 02; 109(44):1682-5. PubMed ID: 6489181
    [Abstract] [Full Text] [Related]

  • 7. Weekend very high-dose intravenous deferoxamine in children with transfusional iron overload.
    Nelson SC, Hennessy JM, McDonough EA, Guck KL.
    J Pediatr Hematol Oncol; 2006 Mar 02; 28(3):182-5. PubMed ID: 16679946
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R, Thévenin M, Bouveret JP, Jeannel F, Rymer JC.
    Arch Fr Pediatr; 1980 Apr 02; 37(4):241-7. PubMed ID: 7406638
    [Abstract] [Full Text] [Related]

  • 10. Reduction of iron overload in thalassemia.
    Piomelli S, Graziano J.
    Birth Defects Orig Artic Ser; 1982 Apr 02; 18(7):339-46. PubMed ID: 7159742
    [No Abstract] [Full Text] [Related]

  • 11. [Thalassaemia intermedia. Clinical and laboratory study. Therapeutic suggestions (author's transl)].
    Triadou P, Girot R, Lapoumeroulie C, Pomarede R, Constant S.
    Nouv Presse Med; 1982 Jan 30; 11(4):253-6. PubMed ID: 6173844
    [Abstract] [Full Text] [Related]

  • 12. [Continuous subcutaneous deferoxamine infusions in thalassemia major. Improvement in glucose tolerance].
    Krüger N, Stubbe P, Tillmann W, Schröter W.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):698-701. PubMed ID: 3486106
    [Abstract] [Full Text] [Related]

  • 13. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E, Baronciani D, Lucarelli G, Giardini C, Galimberti M, Polchi P, Martinelli F, Baldassarri M, Muretto P.
    Bone Marrow Transplant; 1993 May 02; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac complications in homozygous beta-thalassemia.
    Wonke B, Hoffbrand AV, Aldouri MA, Ward SE.
    Prog Clin Biol Res; 1989 May 02; 309():51-6. PubMed ID: 2780750
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 May 02; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 19. [Intravenous administration of deferoxamine in over-night hospitalization: efficacy and good psychological tolerance in thalassemic children].
    Bachelot C, Plantaz D.
    Pediatrie; 1990 May 02; 45(9):619-23. PubMed ID: 2175425
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.